Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Rethinking the evidence on COVID-19 in Africa.
Bejon P. et al, (2025), The Lancet. Infectious diseases
Nanopore adaptive sampling for bacterial identification from periprosthetic joint replacement tissue
Street TL. et al, (2025)
Low-Dose Yellow Fever Vaccine in Adults in Africa
Kimathi D. et al, (2025), New England Journal of Medicine, 392, 788 - 797
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
Kimotho J. et al, (2024), Wellcome Open Research, 8, 350 - 350
Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysis.
Miotto O. et al, (2024), The Lancet. Microbe
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.
Lucinde RK. et al, (2024), BMC infectious diseases, 24
Establishing laboratory reference ranges for adults and children in Kilifi, Kenya
Downs LO. et al, (2024)
Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.
Kinyua AW. et al, (2024), The Journal of infection, 89
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.
Ogwang R. et al, (2024), Antimicrobial agents and chemotherapy, 68
The mRNA content of plasma extracellular vesicles provides a window into molecular processes in the brain during cerebral malaria
Kioko M. et al, (2024), Science Advances, 10
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M. et al, (2024), Life science alliance, 7
Linking Cerebral Malaria Pathogenesis to APOE-Mediated Amyloidosis: Observations and Hypothesis.
Kioko M. et al, (2024), Molecular neurobiology
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations
Kutima B. et al, (2024), Wellcome Open Research, 9, 349 - 349
Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast
Karisa J. et al, (2024), Wellcome Open Research, 8, 151 - 151
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Nkumama IN. et al, (2024), Immunity, 57, 1215 - 1224.e6
Tungiasis among children in Kenya is associated with poor nutrition status, absenteeism, poor school performance and high impact on quality of life
Elson L. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011800 - e0011800
Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi
Asante KP. et al, (2024), The Lancet, 403, 1660 - 1670
Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023
Kapulu M. et al, (2024), Biologicals, 85, 101747 - 101747